Advanced
search

Search results

1 – 10 of 13
View access options
Expert briefing
Publication date: 8 January 2021
Expert Briefings Powered by Oxford Analytica

FDI reached USD40bn in April-September 2020, a 13% rise compared with the corresponding period in 2019. FPI totalled nearly USD23bn in 2020, up 58% from 2019.
View access options
Expert briefing
Publication date: 20 December 2016
Expert Briefings Powered by Oxford Analytica

Abe's government pursues a policy of expanding economic cooperation with Russia as a route to resolving the Southern Kuril/Northern Territories dispute and signing a bilateral…

View access options
Expert briefing
Publication date: 18 October 2021
Expert Briefings Powered by Oxford Analytica

Delhi and Canberra have had a series of high-level bilateral engagements in recent years. The two sides, each wary of Beijing’s growing power, announced a comprehensive strategic…

View access options
Executive summary
Publication date: 29 March 2022
Expert Briefings Powered by Oxford Analytica

INDIA/CHINA: India is more open to Chinese investors
View access options
Expert briefing
Publication date: 5 November 2021
Expert Briefings Powered by Oxford Analytica

Prospects for India in 2022

Location:
PROSPECTS 2022

Meanwhile, GDP is projected by the Reserve Bank of India (RBI) to grow by 9.5% in the fiscal year ending March, rebounding from its 7.3% contraction in 2020/21. Economic goals…

View access options
Expert briefing
Publication date: 1 July 2021
Expert Briefings Powered by Oxford Analytica

The agreement will temporarily cool tensions between the United Kingdom and the EU over the implementation of the Northern Ireland Protocol (NIP). However, underlying problems…

View access options
Expert briefing
Publication date: 29 March 2022
Expert Briefings Powered by Oxford Analytica

Jaishankar later told media that bilateral relations cannot be “normal” if the situation at the India-China border remains “abnormal”. The two sides have only partially disengaged…

View access options
Expert briefing
Publication date: 27 July 2020
Expert Briefings Powered by Oxford Analytica

It has banned 59 Chinese apps and imposed trade and investment barriers. India’s economy is dependent on venture capital from Chinese tech giants, while many of its industries…

View access options
Expert briefing
Publication date: 23 November 2021
Expert Briefings Powered by Oxford Analytica

Prospects for Pakistan in 2022

Location:
PROSPECTS 2022

Separately, the recent Taliban takeover of Afghanistan was a strategic win, given the military-security establishment’s long-standing support for the group. The Taliban’s 'Haqqani…

View access options
Expert briefing
Publication date: 8 September 2021
Expert Briefings Powered by Oxford Analytica

The talks have led to ‘partial agreements’ between President Nicolas Maduro and opposition leader Juan Guaido, but no immediate progress in securing the Maduro government’s goal…

Access

Year

Content type

Refine By Country
{"A":[{"count":"3","title":"Afghanistan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Afghanistan%22"},{"count":"2","title":"Australia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Australia%22"}],"B":[{"count":"3","title":"Bangladesh","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Bangladesh%22"},{"count":"1","title":"Bhutan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Bhutan%22"},{"count":"1","title":"Burkina Faso","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Burkina+Faso%22"}],"C":[{"count":"1","title":"Chad","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Chad%22"},{"count":"10","title":"China","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22China%22"}],"F":[{"count":"1","title":"France","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22France%22"}],"G":[{"count":"1","title":"Guyana","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Guyana%22"}],"H":[{"count":"1","title":"Hong Kong","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Hong+Kong%22"}],"I":[{"count":"9","title":"India","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22India%22"},{"count":"1","title":"Iran","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Iran%22"},{"count":"1","title":"Ireland","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Ireland%22"},{"count":"1","title":"Israel","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Israel%22"}],"J":[{"count":"3","title":"Japan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Japan%22"}],"L":[{"count":"1","title":"Libya","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Libya%22"}],"M":[{"count":"1","title":"Mali","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Mali%22"},{"count":"1","title":"Mauritius","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Mauritius%22"},{"count":"1","title":"Mexico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Mexico%22"},{"count":"1","title":"Myanmar","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Myanmar%22"}],"N":[{"count":"1","title":"Nepal","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Nepal%22"},{"count":"1","title":"Niger","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Niger%22"},{"count":"1","title":"Northern Ireland","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Northern+Ireland%22"}],"P":[{"count":"7","title":"Pakistan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Pakistan%22"}],"R":[{"count":"6","title":"Russia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Russia%22"}],"S":[{"count":"1","title":"Saudi Arabia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Saudi+Arabia%22"},{"count":"2","title":"Singapore","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Singapore%22"}],"T":[{"count":"2","title":"Taiwan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Taiwan%22"}],"U":[{"count":"2","title":"Ukraine","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Ukraine%22"},{"count":"1","title":"United Arab Emirates","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22United+Arab+Emirates%22"},{"count":"3","title":"United Kingdom","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22United+Kingdom%22"},{"count":"2","title":"United Nations","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22United+Nations%22"},{"count":"5","title":"United States","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22United+States%22"}],"V":[{"count":"1","title":"Venezuela","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Venezuela%22"},{"count":"1","title":"Vietnam","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22border+conflict%22+AND+keyword-country%3A%22Vietnam%22"}]}
1 – 10 of 13
Manage cookies

We’re listening — tell us what you think

Join us on our journey